Malignant Adrenal Cortical Neoplasm — Trials

Malignant Adrenal Cortical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04187404	A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma(Spencer)	terminated	Phase 1 / Phase 2	70	EnteromeINDUSTRY	8	Jan 30, 2026	clinicaltrials
NCT03746431	A Phase 1 Study of [225Ac]-FPI-1434 Injection	terminated	Phase 1	78	Fusion Pharmaceuticals Inc.INDUSTRY	3	Jan 7, 2026	clinicaltrials